and <28 days for >/[T1b asymptomatic renal masses. Few reports have examined the effect of prolonged SWT for renal cancer surgery on oncologic outcomes, and those that exist were conducted on a single institution level. We aimed to evaluate whether SWT is associated with treatment outcomes for renal masses on a multi-institution level.
INTRODUCTION AND OBJECTIVES: Current recommendations suggest that nephrectomy or thermal ablation is a recommended treatment option for small renal mass ( 4 cm). This study examined long-term overall survival (OS) of patients managed with delayed and immediate nephrectomy of cT1a renal cancer.
METHODS: We utilized the National Cancer Database (2005 Database ( -2010 to identify 14,677 patients (immediate nephrectomy: 14,050 vs late nephrectomy: 627) aged 70 years with Charlson Comorbidity Index (CCI) 0 and cT1aN0M0 renal cell carcinoma (RCC). Immediate nephrectomy and late nephrectomy were defined as nephrectomy performed 30 days and !180 days from diagnosis respectively. Inverse probability of treatment weighting (IPTW)-adjusted Kaplan-Meier curves and Cox proportional hazards regression analyses were used to compare OS of patients in the two treatment arms. Influence of patient age and CCI on treatment effect was tested by interactions. Additional sensitivity analysis was performed to explore the outcome of delaying nephrectomy for !12 months. Posthoc power calculations were performed. RESULTS: Median age of patients were 55 years with a median follow-up of 82.5 months. IPTW-adjusted Kaplan-Meier curves suggest not significant difference between treatment arms (Hazard ratio, 0.96; 95% confidence interval, 0.73 to 1.26; p[.77 ). This outcome was consistent between all patients regardless of age (p[.48 ). Sensitivity analysis report no difference in overall survival even if nephrectomy was delayed by !12 months (p[.60).
CONCLUSIONS: We report that delayed and immediate nephrectomy for cT1a RCC confers comparable long-term overall survival. The findings of this study support the use of surveillance as a first-line management strategy for small renal masses. METHODS: Retrospective multicenter analysis of patients with clinical T1 RCC who underwent PN. The cohort was divided into cT1a and cT1b subgroups for analysis. Primary outcome was recurrence-free survival (RFS). Secondary outcome was overall survival (OS). Cox regression multivariable analysis (MVA) was used to identify independent predictors of disease recurrence and mortality. KaplanMeier analysis (KMA) were conducted to describe RFS and OS and log-rank test compared survival between positive and negative margin groups.
RESULTS: 2,737 patients met inclusion criteria for analysis (cT1a 1842, cT1b 774, median follow-up 44.4 months); 113 patients (4.3%) had positive surgical margin. MVA for RFS in all cT1 tumors revealed age (HR 1.02, p[0.015) CONCLUSIONS: Our findings suggest that patients with clinical T1b RCC and positive margins following PN are at increased risk of disease recurrence and mortality. Post-operative surveillance and management reflective of a higher risk profile may be warranted for these individuals. Further investigation is requisite.
